Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AANWG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PLBC-002
|
|||||
| Synonyms |
PLBC 002; PLBC002
Click to Show/Hide
|
|||||
| Organization |
PrimeLink BioTherapeutics (Suzhou) Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Triple negative breast cancer [ICD11:2C60-2C65]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.